Clinical efficacy and safety of imatinib in the management of Ph(+) chronic myeloid or acute lymphoblastic leukemia in Chinese patients

por Zhu, Yu, Qian, Si-Xuan
Publicado 2014

Decitabine in combination with low-dose cytarabine, aclarubicin and G-CSF tends to improve prognosis in elderly patients with high-risk AML

por Hong, Ming, Zhu, Han, Sun, Qian, Zhu, Yu, Miao, Yi, Yang, Hui, Qiu, Hai-Rong, Li, Jian-Yong, Qian, Si-Xuan
Publicado 2020

Efficacy and safety of decitabine combined with low-dose cytarabine, aclarubicin, and granulocyte colony-stimulating factor compared with standard therapy in acute myeloid leukemia...

por Chen, Si-Si, Sun, Qian, Cao, Lan, Wu, Wen-Zhong, Xie, Yue, Qiao, Chun, Li, Jian-Yong, Qian, Si-Xuan, Hong, Ming
Publicado 2021

A report on Lineage switch at relapse of CD19 CAR-T therapy for Philadelphia chromosome-positive B-precursor acute lymphoblastic leukemia

por Li, Lan-Zhu, Sun, Qian, Fang, Yu, Yang, Li-Jia, Xu, Zi-Yao, Hu, Jin-Hua, Cao, Lan, Huang, Jia-Yu, Hong, Ming, Li, Jian-Yong, Qian, Si-Xuan
Publicado 2020